Clinical Trial Update: Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating volasertib in combination with azacitidine in Japanese patients with myelodysplastic syndromes or chronic myelomonocytic leukemia; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Volasertib (Volasertib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2018-07-30